Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05790070 · ClinicalTrials.gov registry record · NA
Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle
A NA study of Blood Flow Restriction Training and Betaine Supplementation, sponsored by Baylor University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05790070: Completed NA study of Blood Flow Restriction Training and Betaine Supplementation, sponsored by Baylor University.
NCT05790070 is a NA study of Blood Flow Restriction Training and Betaine Supplementation that has completed, run by Baylor University. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05790070, a NA study of Blood Flow Restriction Training and Betaine Supplementation, has completed, sponsored by Baylor University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to determine whether there is a synergistic effect via combining both low-load blood flow restriction (BFR) training and betaine supplementation loading (6g/day for 14 days) on skeletal muscle anabolic signaling pathways that is mediated by enhancements in intracellular water. These effects are proposed to be greater than either BFR training or betaine supplementation alone or compared to control conditions (high-load non-occluded and/or placebo supplementation).
Primary Outcome
Focal adhesion kinase
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Betaine
Study Locations (1)
Texas
- Baylor University - Waco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-02-01 |
| Est. Completion | 2021-07-30 |
| Phase | NA |
What the finished NCT05790070 record still lists
NCT05790070 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Blood Flow Restriction Training appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05790070 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05790070 about?
NCT05790070 is a clinical study titled "Potential Synergistic Effect of Combined Blood Flow Restriction Training and Betaine Supplementation on Skeletal Muscle". The purpose of the study is to determine whether there is a synergistic effect via combining both low-load blood flow restriction (BFR) training and betaine supplementation loading (6g/day for 14 days) on skeletal muscle anabolic signaling pathways that is mediated by enhancements in intracellular w...
What is the current status of trial NCT05790070?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2021-02-01. Estimated completion is 2021-07-30.
What conditions does trial NCT05790070 study?
This clinical trial studies the following conditions: Blood Flow Restriction Training, Betaine Supplementation.
What interventions are being tested in trial NCT05790070?
The interventions under investigation include: Placebo (OTHER), Betaine (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05790070?
This trial is sponsored by Baylor University, which has 33 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05790070 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05790070's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI